01002nas a2200385   4500000000100000008004100001260001700042653001800059653001400077653002100091653002200112653003000134653002100164653001600185653001600201653002900217653002100246653001100267653001100278653001200289653002000301653001000321653000900331653001300340653001600353653001000369100001700379700001700396700001300413700001700426245014200443300001000585490000700595022001400602       1970                            d  c1970 Jul-Aug10aAcute disease10aBilirubin10aBlood Cell Count10aBlood Coagulation10aBlood Coagulation Factors10aBody Temperature10aBody Weight10aCholesterol10aClinical Trials as Topic10aErythema Nodosum10aFemale10aHumans10aleprosy10aLeukocyte Count10aLiver10aMale10aPlacebos10aThalidomide10aUrine1 aHastings R C1 aTrautman J R1 aEnna C D1 aJacobson R R00aThalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.  a481-70 v11  a0009-9236